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Abstract:
Mitral isthmus ablation forms part of the electrophysiologist’s armoury in the catheter ablation 
treatment of atrial  fibrillation.  It is well  recognised however,  that mitral  isthmus ablation is 
technically  challenging  and  incomplete  ablation  may  be  pro-arrhythmic,  leading  some  to 
question its role. This article first reviews the evidence for the use of adjunctive mitral isthmus 
ablation and its association with the development of macroreentrant perimitral flutter. It then 
describes the practical techniques of mitral isthmus ablation, with particular emphasis on the 
assessment of bi-directional mitral isthmus block. The anatomy of the mitral isthmus is also 
discussed in order to understand the possible obstacles to successful ablation. Finally, novel 
techniques which may facilitate mitral isthmus ablation are reviewed.
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Background
Based on the multiple wavelet hypothesis, the Cox-maze procedure was designed using linear 
lesions to compartmentalize the atria and to interrupt potential macroreentrant circuits which 
may maintain atrial fibrillation (AF) [1]. Interventional electrophysiologists have subsequently 
emulated the surgical technique by attempting to perform radiofrequency linear ablation with 
varying degrees of success. Creating contiguous and transmural linear lesions using the "point-
by-point" technique has proven to be challenging. Of the several proposed linear lesions, only 
mitral isthmus and roof line ablation remain commonly performed as an adjunct to pulmonary 
vein isolation in the treatment of atrial fibrillation [2-3].                                               
A left atrial "isthmus" was first described by Luria et al [4]. They described the phenomenon of 
intra-atrial conduction block in a subset of patients undergoing ablation for left lateral accessory 
pathways. This conduction block was manifested by changes in local ventriculo-atrial time at 
coronary sinus (CS) recording sites and a change in the retrograde atrial activation sequence. 
They  hypothesized  that  this  conduction  block was  due  to  inadvertent  damage  to  a  narrow 
"isthmus" of myocardium between the lateral mitral  annulus and the left inferior pulmonary 
vein  (PV),  analogous  to  the  cavotricuspid  isthmus  of  the  right  atrium.  Due to  the  ease  of 
achieving inadvertent block at the isthmus, they further suggested that this left atrial "isthmus" 
was  an  attractive  target  for  treatment  of  atypical  flutter  which  utilised  the  isthmus  for  the 
macroreentrant circuit and also for left atrial compartmentalization procedures in the treatment 
of atrial fibrillation. While ablation at this left atrial isthmus has been reported in isolated case 
reports for the treatment of atypical perimitral flutter, its feasibility and safety in AF ablation 
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was unreported until described by Jais et al. In 2004 [3].                                            
An ideal linear lesion should connect adjacent anatomic structures or areas of scar which are 
barriers to electrical impulse propagation, should be as short as possible to avoid the risk of 
"gaps", and should be easy to perform with a low risk of complications. Furthermore, it should 
be amenable to easy testing for bidirectional block along the line, allowing for a clear endpoint. 
In  many  respects,  the  mitral  isthmus  initially  appeared  to  fulfil  these  requirements:  It  is 
relatively well defined and anatomically bounded by the mitral annulus and left inferior PV 
ostium (or the anterior/inferior border of ablation lesions during circumferential ablation of the 
left sided pulmonary veins) and its position at the lateral mitral annulus adjacent to the left atrial 
appendage (LAA) and the coronary sinus (CS) facilitates assessment for bi-directional block. 
However, while mitral isthmus block was initially observed with limited ablation for left lateral 
accessory pathway, it is now well recognised that mitral isthmus ablation is challenging and 
may be associated with significant  complications  (see later).                               
Mechanism
While the pathophysiology of AF is still not fully understood, a commonly accepted model is 
that AF may be initiated by triggers or drivers which arise commonly but not exclusively from 
the  pulmonary  veins,  and  is  maintained  or  perpetuated  by  a  suitable  substrate,  under  the 
modulation  of the autonomic  nervous system. While  it  is  also not  always clear  how mitral 
isthmus  ablation  may  contribute  to  the  treatment  and  prevention  of  atrial  fibrillation,  the 
therapeutic efficacy of mitral isthmus ablation is likely to be mediated through its impact on 
substrate modification,  elimination of triggers,  prevention of macroreentry around the mitral 
annulus  or  left  PVs,  modification  of  cardiac  autonomic  innervation  and atrial  de-bulking.  
It is likely that mitral isthmus ablation modifies a large region of the LA substrate for AF by 
eliminating  anatomic  or  functional  reentry  involving both the mitral  isthmus and left-sided 
pulmonary veins [3]. This is evidenced by the transformation from atrial fibrillation to atypical 
macroreentrant perimitral flutter either during the index procedure of AF ablation or follow up, 
particularly when ablation is performed in a step-wise approach [5-6]. Its elimination by mitral 
isthmus ablation appears to be an obligatory step on the way to sinus rhythm in a significant 
subset of patients. In addition to its possible role in the interruption of perimitral flutter, mitral 
isthmus ablation may achieve substrate modification by compartmentalisation and reduction of 
critical  mass needed for fibrillatory conduction,  especially when combined with other linear 
ablations.
Due to the limitations of Moe's multiple wavelet hypothesis [7], there have been suggestions 
that a number of focal high frequency sources may drive and perpetuate AF [8]. These "mother 
rotors"  may  give  rise  to  "vortices  of  electrical  activation"  (spiral  waves)  which  are  self-
sustaining  and  may  be  stationary  or  may  drift  and  subsequently  anchor  to  anatomical 
heterogeneities in the cardiac muscle, i.e. the PV-LA junctions. Mitral isthmus ablation may 
target these "rotors". The cardiac autonomic nervous system, with vagal activation, in particular 
has  been  implicated  in  the  pathogenesis  of  atrial  fibrillation.  In  human  studies,  adjunctive 
modification of the autonomic tone with pulmonary antral ablation has been demonstrated to be 
associated with favourable results [9]. Armour et al. observed ganglionated plexi consistently 
located in 5 atrial regions [10]. One such region is the infero-lateral aspect of the posterior LA, 
which may be targeted by ablation at the mitral isthmus area.                                      
Mitral  isthmus ablation may eliminate arrhythmogenic triggers arising from the ligament  of 
Marshall, an epicardial structure that has been proposed as a source of non-pulmonary ectopy 
which may trigger AF [11]. The ligament of Marshall (LOM) was first described in 1850 as a 
"vestigial fold of the pericardium" and is the remnant of the embryonic left superior vena cava. 
It is located on the epicardial aspect of the left lateral ridge which lies in between the left atrial 
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(LA) appendage and left pulmonary veins (PVs). It consists of blood vessels (the oblique vein 
of Marshall and arterial branches), myocardial sleeve (Marshall bundle) and autonomic nerves. 
The Marshall bundle has variable connections to the CS musculature and the LA myocardium 
in the region of the left lateral ridge. Studies have elegantly demonstrated that the Marshall 
bundle is both an electrical and an autonomic nervous conduit, possessing properties which may 
implicate it in the pathogenesis of AF [12-13]. It has also been shown to be a source of ectopy 
which may trigger AF [14]. Recordings from the LOM during persistent AF have shown rapid 
activation and complex fractionated atrial electrograms which may be associated with driving 
or perpetuating atrial fibrillation [15-16]. Ablation of LOM resulted in vagal denervation and 
blunting of vagally-mediated reduction of atrial tissue effective refractory period which may 
reduce the vulnerability to AF [13]. More recently, LOM is shown to be a critical component of 
the perimitral  circuit  and ethanol ablation has been shown to be feasible and facilitates  the 
achievement  of  bi-directional  mitral  isthmus  block  [17].                               
Clinical  efficacy/literature  review                                    
AF cycle length is a surrogate measure of local atrial  refractoriness and has been shown to 
prolong progressively or immediately prior to termination by drugs [18]. It has been suggested 
as  a  useful  marker  of  substrate  changes  during  catheter  ablation  for  persistent  AF,  with 
prolongation  indicating  participation  of the targeted  tissue in  the AF process.  Experimental 
studies  employing  linear  lesions  have  shown that  they  produce  prolongation  of  the  AFCL 
without changing conduction velocity or the number of wavelets. In human studies, 40% of 
patients had significant AFCL prolongation during linear ablation [5,19]. Specifically, mitral 
isthmus ablation was found to increase the AFCL by about 20 ms which is comparable to that 
observed during pulmonary vein isolation [20]. Mitral isthmus blation was also associated with 
the conversion of AF to sinus rhythm or atrial tachycardia, thus further supporting its role in 
substrate modification. In fact, linear ablation (mainly mitral isthmus) accounted for about 20% 
of  cases  with  AF  termination.                                            
Using the Bordeaux "step wise" approach, AF often converts to atrial tachycardia or flutter and 
elimination of the flutter by linear ablation appears to be an obligatory step on the way to sinus 
rhythm. This may happen during the index procedure or during redo-ablations. In fact, Knecht 
et  al.  reported  that  86%  of  180  patients  undergoing  catheter  ablation  for  persistent  AF 
eventually had mitral isthmus ablation. Patients who did not have both roof and mitral isthmus 
ablation  during the index procedure were found to have a significantly higher  incidence of 
macroreentrant  flutter  during  follow up  [21].                                        
Mitral isthmus ablation also resulted in significantly reduced atrial frequency as measured from 
surface  12  lead  ECG recordings  using  a  combination  of  principal  component  and  Fourier 
transform  algorithms  [22].  More  recently,  mitral  isthmus  ablation  was  demonstrated  to 
eliminate  spectral  components  (lower  frequency  than  the  dominant  frequency)  when  bi-
directional block was achieved even though they were not affected by pulmonary antral ablation 
and ablation of complex fractionated atrial electrograms [23]. This led the authors to speculate 
that these spectral components represent macroreentrant flutters which may co-exist with AF 
and  act  as  lower  frequency drivers  of  AF.                                            
Several studies had reported on the use of linear lesions as a treatment strategy for the catheter 
ablation of AF. Most centres have used it as an adjunct to pulmonary vein isolation while others 
have reported a purely linear approach, i.e the "figure-7 lesion line". However, there is limited 
data on the true clinical efficacy of mitral  isthmus ablation.                                 
The clinical studies which assessed the efficacy of added mitral isthmus ablation (either alone 
or in combination with roof line) are summarised in  Table 1.  6 of the 8 studies showed a 
significant incremental benefit of additional mitral isthmus ablation [3,24-28]. The magnitude 
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of the benefit appeared to be larger for persistent AF (20-40%) compared to paroxysmal AF 
(15-20%). This benefit was both in the reduction of atrial  fibrillation and of macroreentrant 
flutter. One short term study (only 6 months follow up) showed a reduced success with mitral 
isthmus ablation combined with circumferential pulmonary vein ablation [29].  
Mitral isthmus ablation, resumption of conduction and perimitral flutter                       
It  is  clear  from many  studies  that  complete  lines  lead  to  better  outcomes  [21,24-25,  30]. 
Incomplete lines may be proarrhythmic. Fassini et al. showed that patients who had additional 
mitral isthmus ablation but did not achieve bi-directional block did not fare better than patients 
who had pulmonary vein isolation only [24]. Willems et al. also reported that the majority of 
patients who had recurrence from their substrate modification group had at least one incomplete 
linear lesion [25]. In his randomised trial, Pappone et al. found that additional linear ablation 
(roof and mitral isthmus) significantly reduced the incidence of macroreentrant flutters without 
affecting AF recurrence [27]. In a group of patients with persistent AF treated with ablation 
using the Bordeaux stepwise approach, Knecht et al. found that patients who did not require 
linear  ablations  for  AF  termination  experienced  a  significantly  higher  incidence  of 
macroreentrant  flutter  (76%)  either  during  the  index  procedure  or  follow  up  compared  to 
patients who needed linear ablations for AF termination (35%). Incomplete mitral isthmus lines 
more than doubled the risk of developing perimitral flutter post-ablation [21].
Table 1. Studies reporting on the efficacy of mitral isthmus ablation as an adjunct to pulmonary 
vein isolation
CPVA = circumferential pulmonary vein ablation; CTI = cavotricuspid isthmus; MI = mitral isthmus; PVI = 
pulmonary vein isolation; RCT = randomised controlled trial
Even  when  there  is  acute  block,  the  phenomenon  of  resumption  of  conduction  following 
radiofrequency ablation  is  well  recognised and has previously been well  characterised  with 
cavotricuspid isthmus (CTI) ablation [31] and pulmonary vein isolation [32]. However, there is 
limited data on the recurrence of mitral isthmus conduction after an initially successful ablation. 
Based on a small number of patients having redo-procedures due to recurrence of AF and/or 
organised atrial tachycardia, the rate of resumption of conduction of the mitral isthmus in this 
selected population ranged from 62% to 90%, although there is clearly a selection bias [33-36]. 
In a prospective randomised study, Sawhney et al. reported that in patients with paroxysmal 
AF, mitral isthmus ablation increased the risk of subsequently developing atypical left atrial 
flutters  [37].  More  recently,  the  same  group  reported  from  a  retrospective  series  a  high 
incidence  of  mitral  isthmus  reconduction  which  was  significantly  associated  with  the 
development of mitral isthmus dependent flutter [36]. In another retrospective series looking at 
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50 patients who had perimitral flutters either during the index procedure or follow up, prior 
mitral  isthmus  ablation  was  associated  with  a  higher  risk  of  developing  perimitral  flutter, 
suggesting that mitral isthmus ablation may be pro-arrhythmic despite achieving bi-directional 
block  acutely  [38].  However,  these  findings  are  not  reflected  in  the  early  prospective 
randomised trials listed in Table 2.  More prospective randomised studies are needed to resolve 
this issue.
Rostock et al. found that the site of reconduction was predominantly located at the pulmonary 
venous end of the mitral isthmus line (66%) and rarely found epicardially in the CS (6%) [35]. 
This would fit with the peri-venous tissue having the greatest myocardial depth from a post-
mortem study [39]. However, this is not reflected in other studies which reported a need for 
epicardial  CS  ablation  in  the  majority  of  patients  [36]. Our  experience  is  that  most 
reconnections occur at the annular end of the line which could be ablated either endocardially or 
epicardially. This may be explained by the "heat-sink" effect of the epicardial vessels located at 
the annular end of the line.
Table 2: Studies reporting on acute success rate of mitral isthmus ablation.
CS = coronary sinus; Endo = endocardium
A gap in the mitral isthmus line is undoubtedly a pre-requisite for the development of post-
procedure macroreentrant perimitral flutter. Nevertheless, it is clear from several studies that 
these "gaps" do not always lead to clinical tachycardia. In fact, the majority of these "gaps" do 
not manifest as perimitral flutter [35-36]. It may be because "gaps" alone are not sufficient to 
support macroreentrant  tachycardia  and other factors may be necessary for initiation and/or 
perpetuation of macroreentry. In fact, Bai et al. suggested that for treatment of perimitral flutter, 
the strategy of eliminating PV and non-PV triggers may be superior to mitral isthmus ablation 
[40].
Acute  success                                            
Despite  recent  technological  advancement  and  better  understanding  of  the  anatomy,  mitral 
isthmus  ablation  remains  technically  challenging,  often  requiring  substantial  ablation  (> 15 
minutes of radiofrequency energy), high ablation powers (up to 50W) and epicardial ablation 
within the CS (about 70% of patients). In spite of this, acute success rates are only moderate 
(see  Table  2).                                                 
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Assessment of block   
An essential requirement for linear ablation is the creation of a contiguous and transmural line 
of  lesions  resulting  in  complete  conduction  block  capable  of  preventing  macroreentrant 
wavelets. Hence, the ability to assess for complete block is crucial. Validation of bi-directional 
conduction block has been previously described and is facilitated by its proximity to the distal 
CS (the great cardiac vein) and left atrial appendage (LAA) which are located on opposite sides 
of  the  mitral  isthmus  line.                                                
The  general  principles  of  assessing  linear  block  apply  and  criteria  for  confirmation  of  bi-
directional block across the mitral isthmus line are analogous to those used for assessing for 
cavotricuspid isthmus block:
1. Presence of widely spaced double potentials along the line when pacing is performed from 
either  side  of  the  line,  i.e.  "anteriorly"  from the  LAA or  "posteriorly"  from distal  CS.    
2. Activation mapping around the mitral valve annulus when pacing on either side of the line 
showing activation detours such that the activation time is latest adjacent to the line on the side 
opposite to the pacing site. When pacing "anterior" to the line (or from the LAA), there will be 
counter-clockwise activation around the mitral valve annulus and CS activation is proximal to 
distal  (Figure  1).  When  pacing  "posterior"  to  the  line  (i.e.  distal  CS),  there  is  clockwise 
activation around the MVA.
3. Differential pacing utilizing 2 sites on one side of the line and measuring conduction time to 
a fixed point on the other side of the line. If there is complete block, then, pacing from the site  
closer to the line would result in a longer conduction time to the point on the other side of the 
line. E.g. conduction time from CS distal to LAA would be longer than from CS 3-4 to LAA 
(Figure 2)
Jais et al. described the validation of mitral isthmus block using only the ablation catheter and 
CS catheter [3]. The ablation catheter is moved along the line to check for widely spaced double 
potentials during distal CS pacing "posterior" (or "septal" in the paper) to the line. The ablation 
catheter can also be positioned just "anterior" to the line to check for differential pacing and 
confirmation  of  bi-directional  block.                                         
At our institution, we prefer to perform mitral isthmus ablation during continuous pacing from 
the  LAA  (using  the  multipolar  circular  mapping  catheter)  as  this  allows  for  beat-to-beat 
assessment  of  mitral  isthmus conduction  to  guide real-time ablation  and enable  the prompt 
recognition  of mitral  isthmus block (Figure 3).  We have shown in a previous study that  a 
change in CS activation from distal-proximal to proximal-distal predicts bi-directional mitral 
isthmus block with high specificity and sensitivity [41]. One of the pitfall of this technique is 
the  appearance  of  "pseudoblock"  (proximal  to  distal  CS  activation)  secondary  to  the 
disconnection of the distal CS musculature from the atrial myocardium even when there may 
still  be  endocardial  conduction  across  the  mitral  isthmus  [42].  This  can  be  unmasked  by 
performing left atrial endocardial recording immediately posterior to the line to ensure timig is 
identical to or later than the distal coronary sinus electrograms and may be complimented by 
performing an activation map around the mitral valve annulus.
Anatomical  Characteristics  and  Mitral  Isthmus  Ablation                           
Previous  post-mortem  and  in  vivo  studies  using  imaging  modalities  such  as  computed 
tomography, intra-cardiac ultrasound and fluoroscopic angiography have tried to elucidate the 
anatomy of the mitral  isthmus to help guide catheter ablation and to identify  obstacles  to 
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successful ablation [39, 43-45]. It is clear from these studies that the anatomy of the mitral 
isthmus is far from uniform and exhibits significant variation. In post-mortem studies, it has an 
average length of about 35mm and depth of about 4mm. To put it into perspective, it is longer 
than the CTI with similar myocardial thickness. Certain anatomical features were suggested as 
possible obstacles to successful mitral isthmus ablation [39, 43-45]: myocardial depth greater 
than 5 mm; convective cooling by local blood vessels such as the CS and circumflex artery; a 
myocardial sleeve around the CS and continuities with atrial myocardium which may bridge the 
lesion line; crevices in the isthmus area which may hinder safe and efficient radiofrequency 
energy delivery; continuation of atrial myocardium onto the atrial aspect of the mitral valve 
leaflet; and epicardial connections (e.g. the Ligament of Marshall) across the mitral isthmus line 
(Figure 4). Two studies have sought to identify the optimal position for the creation of the 
mitral isthmus line to avoid these anatomic obstacles, but it was clear that there was no fixed 
optimal position due to the anatomical heterogeneity in this area [43-44]. In general, the more 
proximal/"posterior"  positions  would  be  associated  with  greater  myocardial  thickness  and 
higher incidence of the presence of myocardial sleeves around the CS. These sleeves are absent 
in the great cardiac vein and the valve of Viussens or the Vein of Marshall  demarcates the 
junction between the CS and the GCV. More distal/"anterior"  positions are associated with 
greater proximity to the circumflex artery with greater risk of circumflex arterial damage. We 
recommend mitral isthmus ablation at between 3 to 4 o'clock on the mitral valve annulus when 
viewed in the left anterior oblique projection. These early s5.88tudies are limited by the lack of 
correlation between the anatomic obstacles and the likelihood of ablation success. 
Figure 1.  Left atrial 3D electroanatomical (EnSite Velocity, St. Jude Medical) activation maps (A: left anterior  
oblique;  B:  posterior)  during  left  atrial  appendage  pacing  in  the  presence  of  mitral  isthmus  block.  There  is 
counterclockwise activation around the mitral valve annulus resulting in a proximal to distal CS activation (white  
colour  represents  earliest  activation  and  purple  colour  represents  the  latest  activation).  Red  lesions  represent 
circumferential pulmonary vein ablation and blue lesions represent mitral isthmus ablation.
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Figure 2.  A: Electrograms during pacing from CS distal (CSd) bipole, showing time to the mulitpolar catheter  
(PV) positioned in left atrial appendage is 170ms. B: Electrograms during pacing from CS 3-4 bipole, showing  
time  to  the  mulitpolar  catheter  (PV)  positioned  in  left  atrial  appendage  is  156ms.  C:  Left  anterior  oblique 
fluoroscopic image of a patient with previous mitral annular ring. Red lesions represent the mitral isthmus ablation.  
The blue and brown arrows indicate the distance travelled by the impulse when pacing at CSd and CS3-4 bipoles 
respectively when there is mitral isthmus block.   
                                           
Figure 3. Electrograms showing the sudden change in CS activation from distal-to-proximal to proximal-to-distal 
(indicated by red arrows) when pacing from the multipolar catheter (PV) in the left atrial appendage, indicating 
mitral isthmus block. Abl indicates ablation catheter; CSd , coronary sinus distal bipole and CSp, coronary sinus  
proximal bipole.
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Figure 4. Schematic diagram of the cross section along the mitral isthmus from the mitral valve annulus to the left 
inferior pulmonary vein, showing the factors which may hinder mitral isthmus ablation. The blue vessel represents 
the coronary sinus (CS) and the red vessel represents the left circumflex artery.  1 indicates the long and thick  
mitral isthmus; 2, recess/pouch/crevice which may be difficult to get to; 3, muscular sleeve around the CS; 4, 
convective cooling by blood flow in the CS and artery ("heat-sink" hypothesis); 5, Epicardial connections (i.e.  
ligament of Marshall).
More recently, clinical studies have sought to examine the impact of these morphologic features 
on the success of mitral isthmus ablation. Takatsuki et al. found that "high take-off" left inferior 
pulmonary vein [defined as the lower border of the vein having a more cranial position when 
compared  to  the  top  of  the  mitral  annulus  on  computed  tomography  (CT)  imaging]  was 
associated with a significantly lower success rate (50% vs 87%) [46]. They suggested that high 
take-off LIPV may make catheter manipulation more difficult and may result in poor catheter 
stability.  In  a  recent  publication,  Yokokawa  et  al.  found  that  presence  of  a  "pouch"  and 
increased  myocardial  thickness  in  the  area  were  associated  with  failure  to  achieve  mitral 
isthmus block, although they were not significant in multivariate analysis [34]. Longer mitral 
isthmus length was also associated with reduced ablation success [47].                         
Another  unique  anatomical  feature  of  the  mitral  isthmus  line  is  the  presence  of  epicardial 
vascular structures such as the CS and circumflex artery near to the annulus. Blood flow in 
these structures may act as an epicardial "heat-sink", removing heat from the ablation site by 
convective cooling, thereby reducing the efficacy of radiofrequency ablation [43]. Hence, there 
may be a need to perform ablation in the CS itself to target the "protected" epicardial aspect of 
the myocardium. A previous in-vitro study demonstrated this "heat-sink" effect when flow in 
the  marginal  artery  prevented  the  formation  of  transmural  lesions  in  rabbit  ventricular 
myocardium [48]. There is increasing evidence to support this hypothesis. We showed that a 
larger CS diameter was significantly associated with the need for CS ablation as well as the 
total ablation time needed to achieve block [47]. Yokokawa et al. reported a higher prevalence 
of an interposed circumflex artery between the CS and mitral isthmus in cases of unsuccessful 
mitral  isthmus  ablation  [34].  In  that  study,  presence  of  an  interposed  artery  was  the  only 
independent  predictor  of  failure  to  achieve  mitral  isthmus  block.  In  another  recent  study, 
Kurotobi  et  al.  found  that  the  presence  of  a  local  coronary  artery  and  CS  diameter  were 
independent risk factors for unsuccessful mitral isthmus ablation [49]. The authors advocate 
pre-ablation imaging with angiography or CT to visualise local coronary artery to help predict 
the  likelihood  of  achieving  mitral  isthmus  block.                                    
In addition, there are myocardial sleeves around the CS and also the Vein of Marshall which 
may act as epicardial bridges of connection [50]. Endocardial ablation may result in local block 
across the atrial myocardium with ongoing conduction through these epicardial structures [51], 
necessitating high-density endocardial and epicardial mapping (via the coronary sinus and great 
cardiac  vein)  to  identify  insertion  points.                                       
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Complications
Unsurprisingly, in view of the extensive ablation (including within the CS) to achieve mitral 
isthmus block and the close relationship of the circumflex artery and esophagus to the mitral 
isthmus and CS, cardiac tamponade, circumflex artery damage and atrio-esophageal fistula have 
been reported in the literature [3,52-54]. Jais et al. noticed a risk of cardiac tamponade (2 out of 
136)  in  their  original  study  which  was  attributed  to  the  delivery  of  more  than  50W 
endocardially using an irrigated tip catheter [3]. He subsequently recommended limiting the 
maximum power to 42W endocardially. In our centre, we often limit the maximum power to 
40-50W at  the annular  end of the mitral  isthmus line  (overlying  the CS) and we have not 
noticed an excessive risk of cardiac tamponade. In our experience, 50W is sometimes necessary 
to  achieve  mitral  isthmus  block.                                                 
There is a very close relationship between the circumflex artery and the CS. Hasdemir et al. 
found that the circumflex artery was <2mm from the CS catheter at the lateral and anterolateral 
mitral annulus in 24% of patients [55]. This relationship may be even closer at a more distal, 
"anterior" position (i.e. earlier than 3 o'clock on the mitral annulus) (Figure 5). Wittkampf et. 
al. postulated that the risk of damage to the circumflex artery is increased with more 'distal' 
ablation [43]. Takahashi et al. reported the first case of acute circumflex artery occlusion during 
CS ablation to achieve mitral  isthmus block [52]. The incidence was estimated at  1 in 499 
patients in their centre. The low incidence may be explained by the arteries being "protected" 
by  the  "heat-sink"  effect  secondary  to  the  blood  flow.  In  one  case  report,  underlying 
atheromatous disease may have predisposed to occlusion due to reduced protection by impaired 
blood flow [53]. However, the risk factors for coronary artery damage remained unclear. We 
reported a high incidence (28%) of asymptomatic circumflex artery "injury" (stenoses ranging 
from 50%-80%) noticed on coronary angiography after  mitral  isthmus ablation  [56].  These 
stenoses all resolved with intra-coronary nitrates which led us to postulate that the most likely 
mechanism was thermally-induced spasm. Ablation within the CS, proximity of the circumflex 
and CS and a small calibre distal circumflex were found to be risk factors for circumflex artery 
injury.  A  pre-procedural  coronary  angiogram  may  be  helpful  to  help  assess  the  risk  of 
circumflex artery injury (especially if there was significant circumflex artery disease or if the 
circumflex artery was located very close to the CS). Yokokawa et al. also suggested that pre-
procedural  imaging  with  CT  may  identify  interposed  circumflex  artery  which  may  deter 
operator from performing mitral isthmus ablation [34].
The CS is also closely related to the esophagus and hence ablation here may potentially lead to 
the serious complication of atrio-esophageal fistula. Lemola et al. found that 80% of patients 
had a mean separation between the CS and esophagus of about 1mm [57]. In our centre, we find 
the use of esophageal temperature probes helpful in visualizing the oesophagus and alerting us 
when the temperature rise in the esophagus is excessive.                                    
Practical  approach                                                 
While  the use of  a  8mm-tip  non-irrigated  catheter  and/or  non-deflectable  sheaths  had been 
described previously, we prefer to use an irrigated-tip catheter via a deflectable sheath in our 
laboratory  for  added  stability  and  manoeuvrability.  Ablation  is  also  guided  by  3-D 
electroanatomical systems.   
A decapolar catheter is positioned in the coronary sinus (CS) so that the distal bipole is just 
"posterior" to (below) the intended ablation line. We also position the circular mapping catheter 
used for confirmation of pulmonary vein isolation in the left atrial appendage (LAA) for pacing 
above the line as the activation pattern in the coronary sinus provides a beat-to-beat assessment 
of mitral isthmus block during mitral isthmus ablation. The sheath-catheter apparatus is then 
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positioned in the lateral mitral valve annulus (usually between 3 and 4 o'clock in a left anterior 
oblique  view)  guided  by  fluoroscopy  (Figure  6A),  3D  mapping  system and  electrograms. 
Firstly,  the  sheath  is  deflected  and the  catheter  is  extended  out  of  the  sheath  into  the  left  
ventricle.  Then,  with  gentle  clockwise  torque  of  the  sheath  and gradual  withdrawal  of  the 
catheter into the sheath, the catheter is positioned with an atrioventricular ratio of 1:2 at the 
lateral mitral annulus just above the CS distal bipole.
Figure 5. Coronary angiography with the ablation catheter positioned in the coronary sinus (CS) in the left anterior 
oblique (A) and the right anterior oblique (B) views. The relationship between the CS (represented by the ablation  
catheter) and the circumflex artery becomes closer at a more "anterior"/distal position of the CS. Arrow indicates  
spasm of the circumflex artery after ablation at a very "anterior" position. 
Figure 6. Left anterior oblique fluoroscopic picture showing the catheter positions when performing mitral isthmus 
ablation from the endocardial  surface (A) and epicardially in coronary sinus (B).  Quadripolar catheter  (Ao) is  
positioned in the aortic root as reference catheter. Decapolar catheter (CS) is positioned in coronary sinus. Abl  
refers to ablation catheter. The temperature probe (TP) is positioned in the esophagus. A mitral annuloplasty ring is 
also  seen.                                                                     
Ablation  is  then  performed  either  by  the  "point-by-point"  or  the  "drag"  technique. 
Recommended ablation settings: power: 40-50W at the anterior annular end and 30-40W at the 
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posterior venous end of line; temperature: 43-48°C; irrigation: 17-30mls/min. Further clockwise 
torque of the sheath and withdrawal of the catheter will allow the tip of the ablation catheter to 
be moved posteriorly towards the LIPV. Small adjustments to the deflection of the sheath can 
be made to raise or lower the ablation catheter to take the shortest route to the LIPV. Ablation is 
guided by the reduction of local electrogram amplitude. If there is no mitral isthmus block, the 
catheter is moved along the line or just below the line to look for sharp atrial electrograms 
which are earlier than the electrogram on the CS distal bipole.                                                   
If there are no sharp electrograms which are earlier than CS distal bipole, ablation is performed 
epicardially in the CS at a site overlying the endocardial line. The sheath-catheter apparatus is 
withdrawn into the right atrium. The catheter is advanced into the distal CS beyond the CS 
distal  bipole  with  the  sheath  positioned  at  the  CS os  for  support.  The  ablation  catheter  is  
deflected  towards the endocardial  surface opposite  to the lesions delivered endocardially  to 
minimise the risk of circumflex artery damage (Figure 6B). Recommended ablation settings 
are: power: 25-30W; temperature: 43-48°C; irrigation: 17-30mls/min.                                     
If  required,  an  electroanatomical  activation  map  could  be  performed  just  below the  mitral 
isthmus line during LAA pacing to help identify the earliest breakthrough site (Figure 7). In 
spite of all these efforts, acute mitral isthmus block may not be achieved in up to about 5-10% 
of patients, presumably due to local myocardial edema preventing full-thickness necrosis.
Figure 7. Activation maps in left anterior oblique (A) and left lateral (B) views during pacing from the left atrial  
appendage showing the breakthrough point in distal coronary sinus (represented by the earliest activation, white 
colour). Ablation in the coronary sinus (green lesions) subsequently achieved mitral isthmus block. The red lesions 
represent circumferential pulmonary vein ablation and blue lesions represent endocardial mitral isthmus ablation.
Alternative  Isthmus                                      
Previously, an alternative septal/medial left atrial isthmus (from the right inferior pulmonary 
vein  to  the  mitral  annulus)  was  suggested  as  an  alternative  to  the  lateral  mitral  isthmus. 
However, it  was found to have a less favourable anatomy, i.e. a longer isthmus and greater 
percentage of ridges [45]. Wittkampf et al. also found that the myocardial thickness increases at 
a more medial mitral isthmus position [43]. In a group of patients undergoing surgical cryo-
ablation with concomitant valve surgery, bi-directional block was achieved in about two-thirds 
of lateral isthmus ablation but not achieved in any medial isthmus ablation [30].                          
Tzeis et al. reported on the safety and feasibility of a modified anterior line extending from the 
anterior/anterolateral  mitral  annulus  to  the  orifice  of  the  left  superior  pulmonary  vein,  just 
medial  to  the  LAA  [58].  Although  it  was  very  effective  in  terminating  perimitral  flutters 
(>95%), bi-directional  block was only achieved in  86% of cases.  The mean procedure and 
ablation time were 28.9 mins and 16.6 minutes respectively, which were comparable to those 
reported for the conventional lateral mitral isthmus. With this technique, there is no need for 
ablation within the CS which may be desirable in view of the complications associated with CS 
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ablation. Inadvertent isolation of the LAA or delayed activation of the LAA may be potential 
drawbacks.         
Pak et al. have recently taken this further by proposing voltage map-guided left atrial anterior 
wall ablation [59]. He reported a correlation between low voltage areas on the left atrial anterior 
wall and the LA-aorta contact area on multislice cardiac magnetic resonance scan. The mean 
voltage in this area was significantly lower than that at the lateral mitral annulus. Although the 
mean length of the ablation line at this anterior site was longer than the lateral mitral isthmus,  
they reported a higher success rate at achieving bi-directional block (albeit only 68% vs 32%). 
It was also associated with a better clinical outcome after single procedure.                           
New  techniques                                            
In order to overcome potential obstacles to mitral isthmus ablation and to improve success and 
ease of ablation, several novel techniques have been suggested. There is increasing evidence to 
support the "heat-sink" hypothesis (see above). To reduce the "heat-sink" effect, the blood flow 
in the CS could be temporarily stopped with an occlusion balloon. D'Avila et al. first reported 
that  balloon occlusion of  the CS facilitated  transmural  ablation  at  the mitral  isthmus in  an 
animal study [60]. We performed a randomized study in humans and also found that balloon 
occlusion  of  the  CS  using  an  air-filled  balloon  improved  mitral  isthmus  ablation  by 
significantly reducing the need for epicardial CS ablation, as well as reducing mean total and 
CS  ablation  times  [61].  However,  in  our  study,  acute  success  rate  was  not  significantly 
improved. Despite the promising results, we cannot recommend this to be performed routinely 
due to the lack of custom-designed kit for balloon occlusion of the CS. 
Another potential  barrier  to successful mitral  isthmus ablation is the lack of stability of the 
ablation catheter and poor tissue contact. Steerable sheaths could confer the theoretical benefit 
of improved navigation and stability [62]. Specifically, they could allow for the more parallel 
orientation of the ablation catheter to the mitral isthmus to improve ablation efficacy, but also 
allow the ablation catheter to be positioned perpendicularly to "dig" into pouches, which could 
be possible anatomical barriers to successful mitral isthmus ablation [34]. The use of steerable 
sheaths had previously been demonstrated to facilitate PVI [63-65] and CTI ablation [66]. A 
recent randomized study showed that steerable sheaths significantly improve the efficacy of 
ablation at the mitral isthmus [62]; the acute rate of mitral isthmus block was 97.5%, mean 
ablation time was 11.8±6.4 mins and the need for CS ablation was only 12.5%. This finding 
represented a major improvement on previous published results (Table 2). 
We have recently reported on the safety and feasibility study on mitral isthmus ablation using a 
robotic navigation system (Hansen Sensei Robotics). This study enrolled the first 30 patients 
who  had  mitral  isthmus  ablation  and  the  results  included  our  learning  curve.  Overall,  we 
achieved an acute success rate of 97%, the need for CS ablation was 53% and mean ablation 
time  was  14±7  min  [67].                                         
Point-by-point ablation is time-consuming and challenging and may lead to the creation of non-
contiguous  lesions  which may be pro-arrhythmic.  Circular  multielectrode  ablation  catheters 
using duty-cycled bipolar and unipolar radiofrequency (RF) energy have been demonstrated to 
be effective in achieving pulmonary vein isolation [68]. Using the same technology, a novel 
hexapolar  linear  multielectrode  catheter  has  been developed and has the potential  to  create 
contiguous lesions with less radiofrequency applications. In addition to the ability to deliver 
radiofrequency energy simultaneously from all poles, it also allows for simultaneous mapping 
for the entire length and can potentially aid in the prompt identification of conduction gaps [69]. 
While  it  may be promising  for  CTI ablation  [70],  the  initial  experience  for  mitral  isthmus 
ablation has been disappointing with an acute success of only 29% [71]. Further bigger multi-
centre studies are needed to fully assess the impact of this technology  on  mitral   isthmus 
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ablation.    
In view of possible circumflex artery and oesophageal damage, our group had explored the 
possibility of using cryo-ablation (delivered in a point-by-point fashion using Freezor Max with 
an 8 mm ablation  tip).  While  cryo-ablation  was safe and effective,  it  is  currently too time 
consuming  for  it  to  be  a  practical  alternative.                               
Conclusion
While the acute success rate of mitral isthmus ablation is continuing to improve due to better 
technology and tools, recurrence of conduction still occurs in many cases and may pre-dispose 
patients to clinical tachycardia. The challenge remains to achieve durable mitral isthmus block. 
The benefits of adjunctive mitral isthmus ablation also needs to be clarified by well-designed 
randomised  controlled  trials.                                         
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